The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunology Drug-Global Market Insights and Sales Trends 2024
Synopsis
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
The global Immunology Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunology Drug in various end use industries. The expanding demands from the Hospitals, Clinics and Cancer Research Centers and Institutes,, are propelling Immunology Drug market. Monoclonal Antibodies (mAb), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibody Drug Conjugates segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunology Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunology Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunology Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunology Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunology Drug covered in this report include Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech and F. Hoffmann-La Roche Ltd., etc.
The global Immunology Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Global Immunology Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunology Drug market, Segment by Type:
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Global Immunology Drug market, by Application
Hospitals
Clinics
Cancer Research Centers and Institutes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
The global Immunology Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunology Drug in various end use industries. The expanding demands from the Hospitals, Clinics and Cancer Research Centers and Institutes,, are propelling Immunology Drug market. Monoclonal Antibodies (mAb), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibody Drug Conjugates segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunology Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunology Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunology Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunology Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunology Drug covered in this report include Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech and F. Hoffmann-La Roche Ltd., etc.
The global Immunology Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Global Immunology Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunology Drug market, Segment by Type:
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Global Immunology Drug market, by Application
Hospitals
Clinics
Cancer Research Centers and Institutes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Immunology Drug Market Overview
1.1 Immunology Drug Product Overview
1.2 Immunology Drug Market Segment by Type
1.2.1 Monoclonal Antibodies (mAb)
1.2.2 Antibody Drug Conjugates
1.2.3 Immunosuppressive medication
1.2.4 Others
1.3 Global Immunology Drug Market Size by Type
1.3.1 Global Immunology Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Immunology Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Immunology Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immunology Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Immunology Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Immunology Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Immunology Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Immunology Drug Sales Breakdown by Type (2018-2023)
2 Global Immunology Drug Market Competition by Company
2.1 Global Top Players by Immunology Drug Sales (2018-2023)
2.2 Global Top Players by Immunology Drug Revenue (2018-2023)
2.3 Global Top Players by Immunology Drug Price (2018-2023)
2.4 Global Top Manufacturers Immunology Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immunology Drug Market Competitive Situation and Trends
2.5.1 Immunology Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Immunology Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunology Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Immunology Drug Market
2.8 Key Manufacturers Immunology Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immunology Drug Status and Outlook by Region
3.1 Global Immunology Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Immunology Drug Historic Market Size by Region
3.2.1 Global Immunology Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Immunology Drug Sales in Value by Region (2018-2023)
3.2.3 Global Immunology Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Immunology Drug Forecasted Market Size by Region
3.3.1 Global Immunology Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Immunology Drug Sales in Value by Region (2024-2029)
3.3.3 Global Immunology Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Immunology Drug by Application
4.1 Immunology Drug Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Cancer Research Centers and Institutes
4.2 Global Immunology Drug Market Size by Application
4.2.1 Global Immunology Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Immunology Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Immunology Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immunology Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Immunology Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Immunology Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Immunology Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Immunology Drug Sales Breakdown by Application (2018-2023)
5 North America Immunology Drug by Country
5.1 North America Immunology Drug Historic Market Size by Country
5.1.1 North America Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Immunology Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Immunology Drug Sales in Value by Country (2018-2023)
5.2 North America Immunology Drug Forecasted Market Size by Country
5.2.1 North America Immunology Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Immunology Drug Sales in Value by Country (2024-2029)
6 Europe Immunology Drug by Country
6.1 Europe Immunology Drug Historic Market Size by Country
6.1.1 Europe Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Immunology Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Immunology Drug Sales in Value by Country (2018-2023)
6.2 Europe Immunology Drug Forecasted Market Size by Country
6.2.1 Europe Immunology Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Immunology Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Immunology Drug by Region
7.1 Asia-Pacific Immunology Drug Historic Market Size by Region
7.1.1 Asia-Pacific Immunology Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Immunology Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Immunology Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Immunology Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Immunology Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Immunology Drug Sales in Value by Region (2024-2029)
8 Latin America Immunology Drug by Country
8.1 Latin America Immunology Drug Historic Market Size by Country
8.1.1 Latin America Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Immunology Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Immunology Drug Sales in Value by Country (2018-2023)
8.2 Latin America Immunology Drug Forecasted Market Size by Country
8.2.1 Latin America Immunology Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Immunology Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Immunology Drug by Country
9.1 Middle East and Africa Immunology Drug Historic Market Size by Country
9.1.1 Middle East and Africa Immunology Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Immunology Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Immunology Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Immunology Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Immunology Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Immunology Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories Immunology Drug Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Active Biotech
10.2.1 Active Biotech Company Information
10.2.2 Active Biotech Introduction and Business Overview
10.2.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Active Biotech Immunology Drug Products Offered
10.2.5 Active Biotech Recent Development
10.3 Eli Lilly and Company
10.3.1 Eli Lilly and Company Company Information
10.3.2 Eli Lilly and Company Introduction and Business Overview
10.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly and Company Immunology Drug Products Offered
10.3.5 Eli Lilly and Company Recent Development
10.4 Autoimmune Inc.
10.4.1 Autoimmune Inc. Company Information
10.4.2 Autoimmune Inc. Introduction and Business Overview
10.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Autoimmune Inc. Immunology Drug Products Offered
10.4.5 Autoimmune Inc. Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Immunology Drug Products Offered
10.5.5 Pfizer Recent Development
10.6 GlaxoSmithKline plc
10.6.1 GlaxoSmithKline plc Company Information
10.6.2 GlaxoSmithKline plc Introduction and Business Overview
10.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
10.6.5 GlaxoSmithKline plc Recent Development
10.7 Seattle Genetics
10.7.1 Seattle Genetics Company Information
10.7.2 Seattle Genetics Introduction and Business Overview
10.7.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Seattle Genetics Immunology Drug Products Offered
10.7.5 Seattle Genetics Recent Development
10.8 Genentech
10.8.1 Genentech Company Information
10.8.2 Genentech Introduction and Business Overview
10.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Genentech Immunology Drug Products Offered
10.8.5 Genentech Recent Development
10.9 F. Hoffmann-La Roche Ltd.
10.9.1 F. Hoffmann-La Roche Ltd. Company Information
10.9.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
10.9.5 F. Hoffmann-La Roche Ltd. Recent Development
10.10 Eisai Co.
10.10.1 Eisai Co. Company Information
10.10.2 Eisai Co. Introduction and Business Overview
10.10.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Eisai Co. Immunology Drug Products Offered
10.10.5 Eisai Co. Recent Development
10.11 Bayer AG
10.11.1 Bayer AG Company Information
10.11.2 Bayer AG Introduction and Business Overview
10.11.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Bayer AG Immunology Drug Products Offered
10.11.5 Bayer AG Recent Development
10.12 Sanofi Aventis LLC.
10.12.1 Sanofi Aventis LLC. Company Information
10.12.2 Sanofi Aventis LLC. Introduction and Business Overview
10.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Sanofi Aventis LLC. Immunology Drug Products Offered
10.12.5 Sanofi Aventis LLC. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immunology Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immunology Drug Industrial Chain Analysis
11.4 Immunology Drug Market Dynamics
11.4.1 Immunology Drug Industry Trends
11.4.2 Immunology Drug Market Drivers
11.4.3 Immunology Drug Market Challenges
11.4.4 Immunology Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immunology Drug Distributors
12.3 Immunology Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
